In vivo and in vitro Characterization of a Partial Mu Opioid Receptor Agonist, NKTR-181, Supports Future Therapeutic DevelopmentWendy Walwyn, Isabel Bishop, Vartan Matossian et al.|Frontiers in Pain Research|2021Cited by 4